Figure 3.
SDS-PAGE of Rituximab in reducing and non-reducing conditions.
Non-reducing conditions: 1: Zytex, 2: purified Rituximab, 3: DOTA-Rituximab
Reducing conditions: 4: DOTA-Rituximab, 5: purifies Rituximab, 6: Zytex
M: Molecular marker
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.